---
title: Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers
euct_id: 2026-525448-14-00
phase: Phase 2
status: Not yet recruiting
sponsor: Orion Corporation
canonical_url: "https://parkinsonspathways.com/trials/eu/2026-525448-14-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2026-525448-14-00"
ctis_last_updated: "2026-05-23T03:30:50.515547197"
source: EU Clinical Trials Information System (CTIS)
---
# Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers

**EU CT Number:** [2026-525448-14-00](https://euclinicaltrials.eu/ctis-public/view/2026-525448-14-00)

## Key Facts

- **Phase:** Phase 2
- **Status:** Not yet recruiting
- **Sponsor:** Orion Corporation
- **Start Date:** 2026-05-11
- **Completion Date:** 2026-07-30
- **Conditions:** Parkinson disease, Disease Parkinson´s

## Member States

Trial is authorized in 1 member state: Czechia.

## Sites (1)

- Cepha s.r.o., Plzen, Czechia

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Maximum age:** 64 Years
- **Sex:** ALL

```
Condition: Parkinson disease; Disease Parkinson´s
Age groups: adults 18-64
Sex: male, female
Includes a vulnerable population.
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2026-525448-14-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2026-525448-14-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2026-525448-14-00*